Platelets and phospholipids in tissue factor-initiated thrombin generation

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 660-667

  Butenas, S ^a   Branda, R F ^a   Van't Veer, C ^a   Cawthern, K M ^a   Mann, K G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Factor V; Phospholipids; Platelets; Thrombocytopenia; Tissue factor

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; CYTARABINE; FIBRINOGEN; IDARUBICIN; PHOSPHOLIPID; PROTHROMBIN; THROMBIN; THROMBOPLASTIN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLEEDING; BLOOD CLOTTING; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CONTROLLED STUDY; DISEASE MODEL; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; IN VIVO STUDY; PANCYTOPENIA; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0034898546     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616110     Document Type: Article

References (51)

1. Coagulation cascade: An overview
2. Generation of prothrombin converting activity and the exposure of phosphatidylserine at the outer surface of platelets
3. The role of activated human platelets in prothrombin and factor X activation
4. Factor XI activation in a revised model of blood coagulation
5. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma
6. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases
7. An integrated study of fibrinogen during blood coagulation
8. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
9. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia
10. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes
11. An endothelial cell-dependent pathway of coagulation
12. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations
13. Tissue factor pathway inhibitor and the revised theory of coagulation
14. Changes in membrane phospholipid distribution during platelet activation
15. Surface-dependent reactions in the propagation phase of blood coagulation
16. Role of the membrane surface in the activation of human coagulation factor X
17. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X
18. The effect of membrane composition on the hemostatic balance
19. Regulation of prothrombinase activity by protein S
20. Kinetics of human factor VII activation
21. A model for the tissue factor pathway to thrombin. I. An empirical study
22. Blood clotting in minimally altered whole blood
23. Antiplatelet agents in tissue factor-induced blood coagulation
24. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II
25. Blood coagulation in hemophilia A and hemophilia C
26. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles
27. A simplified procedure for purification of human prothrombin, factor IX and factor X
28. Isolation of functional human coagulation factor V by using a hybridoma antibody
29. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III
30. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin
31. Preparation of suspension of washed platelets from humans
32. "Clotspeed", a mathematical simulation of the functional properties of prothrombinase
33. The role of phospholipids and factor Va in the prothrombinase complex
34. The role of phospholipid and factor VIIIa in the activation of bovine factor X
35. A model of the tissue factor pathway to thrombin
36. Approach to bleeding
37. Drug-induced thrombocytopenia
38. Platelets acquire a secretion defect after high-dose chemotherapy
39. Platelet transfusions: The 20,000/microL trigger
40. Aplastic anaemia - Aetiology and clinical features
41. Prophylactic platelet transfusions in children with acute leukemia: A dose response study
42. The bleeding time does not predict surgical bleeding
43. A critical reappraisal of the bleeding time
44. Platelet coagulant activities and hemostasis: A hypothesis
45. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation
46. Platelet morphology
47. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder
48. Factor V (Quebec): A bleeding diathesis associated with a qualitative platelet factor V deficiency
49. Isolation and study of an acquired inhibitor of human coagulation factor V
50. Abnormal formation of the prothrombinase complex: Factor V deficiency and related disorders
51. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin